Adenotonsillar Hypertrophy,Under 12 Years.

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Adenotonsillar Hypertrophy,Under 12 Years. trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT01267942

Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Enhancin in Prevention of Postadenotonsillectomy Morbidity.

Null hypothesis; The efficacy of Enhancin\]Co-Amoxiclav given as a single intravenous dose at induction is not better than a five days oral course of the same g…

Kenya126 participantsStarted 2008-05

Treatment: Enhancin